[659] Clinicopathologic Significance of Cyclooxygenase-2 Overexpression in Colorectal Adenocarcinoma

SM Jang, KS Jang, KH Lee, SS Paik. Hanyang University, Seoul, Republic of Korea

Background: Cyclooxygenase-2 (COX-2) plays an important role in colorectal cancer development and is frequently up-regulated in colorectal cancer. The purpose of this study was to investigate COX-2 overexpression in colorectal adenocarcinoma and to evaluate the correlation with the clinicopathological parameters and p53 expression, as well as its effect on patient survival.
Design: We evaluated the expression of COX-2 and p53 on the tissue microarray of 414 colorectal adenocarcinomas by immunohistochemistry. Data was analyzed by Fisher's exact test, chi-square test, one-way ANOVA, Cox regression hazards model and log-rank test with Kaplan-Meier curves.
Results: The cytoplasmic COX-2 overexpression was detected in 56.3% of colorectal adenocarcinoma samples. COX-2 overexpression was correlated with favorable clinicopathologic factors in lymph node metastasis (p = 0.002), AJCC and Dukes' stage (p = 0.008 and p = 0.017, respectively), and lymphatic invasion (p = 0.001). Other characteristics associated with COX-2 overexpression were colonic site of tumor (p = 0.008) and poor differentiation (p = 0.017). There was no correlation between COX-2 overexpression and p53 expression (p = 0.485). In univariate survival analysis, patients with COX-2 overexpression revealed better overall survival and disease-free survival (p = 0.021 and p = 0.017, respectively, log-rank test). In multivariate survival analysis with the Cox proportional hazards model, COX-2 overexpression was an independent prognostic factor of overall survival and disease-free survival (p = 0.029 and p = 0.039, respectively).
Conclusions: COX-2 overexpression was significantly associated with favorable clinicopathologic phenotype and an indicator of better survival in our cohort of colorectal cancer patients.
Category: Gastrointestinal

Tuesday, March 23, 2010 9:30 AM

Poster Session III # 110, Tuesday Morning


Close Window